EDITAS MEDICINE INC's ticker is and the CUSIP is 28106W953. A total of 5 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258,180 | -11.1% | 33,100 | -6.2% | 0.00% | – |
| Q2 2023 | $290,519 | +220.6% | 35,300 | +182.4% | 0.00% | – |
| Q1 2023 | $90,625 | -82.5% | 12,500 | -78.6% | 0.00% | – |
| Q4 2022 | $518,008 | -54.2% | 58,400 | -36.9% | 0.00% | – |
| Q3 2022 | $1,132,000 | +62.4% | 92,500 | +57.0% | 0.00% | – |
| Q2 2022 | $697,000 | – | 58,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 50,000 | $2,054,000 | 0.06% |
| GROUP ONE TRADING, L.P. | 245,400 | $10,081,000 | 0.01% |
| SIMPLEX TRADING, LLC | 114,100 | $6,448,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 26,500 | $1,089,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |